MAFLD is linked to lower HBV DNA levels in chronic hepatitis B: clinical and transcriptomic insights. [PDF]
Gao X, Du X.
europepmc +1 more source
We investigated the frequency and serological correlates of occult hepatitis B virus infection (OBI) and the potential impact of a highly sensitive assay for HBsAg in subjects infected by human immunodeficiency virus (HIV) or hepatitis C virus (HCV), who
Klizia Mizzoni +9 more
core +1 more source
Pilot Evaluation of Simplified HBV DNA Extraction-LAMP Workflows for Hepatitis B Molecular Testing in Resource-Limited Settings. [PDF]
Kham-Kjing N +6 more
europepmc +1 more source
Diagnostic value of PNI and MLR in cirrhotic patients with negative HBV DNA and positive HBV RNA:A nomogram--based evaluation model. [PDF]
Li M +5 more
europepmc +1 more source
Droplet Digital PCR Measurement of HBV DNA in On-Treatment Chronic HBV Patients: Association With HCC Development and Outcomes. [PDF]
Hui RW +6 more
europepmc +1 more source
Association of baseline HBcAg and HBV DNA with persistent detectability of HBV RNA during NA therapy. [PDF]
Wu L +10 more
europepmc +1 more source
Hepatitis B in Isolated Anti-HBc Carriers: Predictors of Detectable HBV DNA and Implications for Risk-Stratified Screening. [PDF]
Zeybek H.
europepmc +1 more source
Development and application of a real-time VPCR method for ultra-fast quantitative analysis and Visual Detection of HBV-DNA. [PDF]
Zhao T +7 more
europepmc +1 more source
Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients. [PDF]
PLOS One Staff.
europepmc +1 more source

